Showing results (81-90 of 94) with videos related to
Sort By:
Pageof 10
Diagnostic Pathology|September 22, 2020
Clinicopathological findings of pediatric NTRK fusion mesenchymal tumorsJeongwan Kang, Jin Woo Park, Jae-Kyung Won, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|August 30, 2025
Transcriptional intermediary factor 1 gamma prevents lung inflammation and fibrosis via alveolar type 2 cells, fibroblasts, and macrophagesDodam Moon, Hyomin Park, Tae Yoon Kim, et al.Cancer Immunology, Immunotherapy : CII|January 3, 2021
Discovery of acquired molecular signature on immune checkpoint inhibitors in paired tumor tissuesShin Hye Yoo, Jihui Yun, Bhumsuk Keam, et al.European Journal of Cancer (Oxford, England : 1990)|August 15, 2022
TCF1<sup>+</sup>PD-1<sup>+</sup> tumour-infiltrating lymphocytes predict a favorable response and prolonged survival after immune checkpoint inhibitor therapy for non-small-cell lung cancerJaemoon Koh, Sehui Kim, Yeon Duk Woo, et al.European Journal of Cancer (Oxford, England : 1990)|July 9, 2024
Resistance mechanisms of EGFR tyrosine kinase inhibitors, in EGFR exon 20 insertion-mutant lung cancerSiyeon Park, Seongyeol Park, Tae Min Kim, et al.Journal for Immunotherapy of Cancer|March 6, 2025
Cell-intrinsic PD-L1 signaling drives immunosuppression by myeloid-derived suppressor cells through IL-6/Jak/Stat3 in PD-L1-high lung cancerHyein Jeong, Jaemoon Koh, Sehui Kim, et al.Elife|July 5, 2021
Soluble Fas ligand drives autoantibody-induced arthritis by binding to DR5/TRAIL-R2Dongjin Jeong, Hye Sung Kim, Hye Young Kim, et al.Experimental & Molecular Medicine|August 23, 2022
DNA methylome and single-cell transcriptome analyses reveal CDA as a potential druggable target for ALK inhibitor-resistant lung cancer therapyHaejeong Heo, Jong-Hwan Kim, Hyun Jung Lim, et al.Cell Reports|July 27, 2017
Cytosolic Pellino-1-Mediated K63-Linked Ubiquitination of IRF5 in M1 Macrophages Regulates Glucose Intolerance in ObesityDonghyun Kim, Ho Lee, Jaemoon Koh, et al.Theranostics|September 1, 2020
Reciprocal change in Glucose metabolism of Cancer and Immune Cells mediated by different Glucose Transporters predicts Immunotherapy responseKwon Joong Na, Hongyoon Choi, Ho Rim Oh, et al.Pageof 10